A Rare Fatal Case of COVID-19 Co-Infection with Community-Acquired Methicillin-Resistant Staphylococcus Aureus in a Diabetic Patient
This case underscores the critical need for screening and treating bacterial co-infections in COVID-19 management, particularly in immunocompromised hosts, due to the enhanced pathogenicity of CA-MRSA strains. Early recognition and appropriate antimicrobial therapy are essential in reducing the impact of such co-infections.
Authors
- Zhaolu Meng
- Qiao Yang (ORCID: https://orcid.org/0000-0001-7401-2168)
- Feng Zhao (ORCID: https://orcid.org/0000-0002-7630-9819)
- Rehanguli Wuxiuer
Institutions
- Sir Run Run Shaw Hospital (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/idr.s512885
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00